THC BioMed Announces J.D. Springett Joins Advisory Board
(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/29/15 -- THC BioMed Intl Ltd. ("THC") (CSE: THC)(OTC PINK: THCBF)(FRANKFURT: TFHC) is pleased to announce it has appointed Mr. J. D. Springett to the company's newly formed advisory board. Mr. Springett brings 7 years' experience in the newly emerging Medical Cannabis industry, beginning with Cannabis Science in 2008. He has extensive knowledge and experience in the medical marijuana sector and is highly sought after as a design and training expert for licensed medical marijuana facilities. He has been a valuable consultant for several companies seeking a MMPR license. Mr. Springett will be a valuable addition to our highly trained scientific consulting team.
THC's vision is to be on the leading edge of scientific research and development of products and services related to the medical cannabis industry while creating a standard of excellence. As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry.
Please visit our website for a more detailed description of our business and services available.
Forward-Looking Information:
This press release contains certain "forward-looking information" within the meaning of applicable securities law. The forward-looking statements include that (i) Mr. Springett will be valuable in helping the Company achieve its goal of global growth and (ii) As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "would", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. These statements are based on expectations and assumptions made by the management of THC at the date the information is provided, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. For a description of the risks and uncertainties facing THC and its business and affairs, readers should refer to THC's Listing Statement, Financial Statements and its Management's Discussion and Analysis on .
Contacts:
THC Biomed Intl Ltd.
John Miller
President and CEO
604 682-1643
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.07.2015 - 12:00 Uhr
Sprache: Deutsch
News-ID 409934
Anzahl Zeichen: 4243
contact information:
Town:
VANCOUVER, BRITISH COLUMBIA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 207 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"THC BioMed Announces J.D. Springett Joins Advisory Board"
steht unter der journalistisch-redaktionellen Verantwortung von
Thelon Capital Ltd. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
